Proliferative state of the urothelium with benign and atypical changes. Correlation with transferrin and epidermal growth factor receptors and blood group antigens
- 1 September 1993
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 171 (1) , 39-47
- https://doi.org/10.1002/path.1711710109
Abstract
We attempted to investigate how the proliferative state of the urothelium correlates with the reactivity for transferrin (Tf) and epidermal grown factor (EGF) receptors and the blood group (BG) antigen. We examined morphologically normal urothelium (34 cases), benign inflammatory and reactive conditions (24 cases), and atypical changes (20 cases) without exophytic or invasive neoplasia. The Ki67 nuclear antigen was used as the proliferation index and was complemented with the in vitro BrdU incorporation assay in 32 cases. The immunohistochemical reactions for Tf and EGF receptors and for the appropriate BG antigen were scored semi-quantitatively on frozen sections. We found that normal urothelium has very low Ki67 and BrdU indices as well as low reactivity for the two receptors and is almost invariably positive for the BG antigen. Benign conditions such as inflammation and metaplasia significantly augment the proliferation indices and the Tf receptor with little change in the EGF receptor and no significant effect on the BG antigen. Moderate atypia includes biologically heterogeneous cases which vary widely in proliferation and receptor expression. Severe atypia-carcinoma in situ is consistently associated with markedly elevated proliferation indices, strong Tf receptor reactivity, and depressed BG antigen. The reactivity for EGF receptor is less consistently increased. Cases with a combination of strong EGF receptor reactions and absence of the expected BG antigen have a poor prognosis with progression to invasive cancer.Keywords
This publication has 19 references indexed in Scilit:
- Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.Journal of Clinical Pathology, 1993
- The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applicationsJournal of Molecular Histology, 1992
- Cell Cycling in Bladder Carcinoma Determined by Monoclonal Antibody Ki67British Journal of Urology, 1990
- Transferrin Receptor Expression in Primary Superficial Human Bladder Tumours Identifies Patients who Develop RecurrencesBritish Journal of Urology, 1990
- Review: assessment of cell proliferation in histological material.Journal of Clinical Pathology, 1990
- EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURSThe Lancet, 1985
- Human squamous cell lung cancers express increased epidermal growth factor receptors.Journal of Clinical Investigation, 1984
- CORRELATION OF TRANSFERRIN RECEPTOR EXPRESSION WITH HISTOLOGICAL CLASS AND OUTCOME IN NON-HODGKIN LYMPHOMAThe Lancet, 1983
- The transferrin receptorTrends in Biochemical Sciences, 1982
- Novel surface antigen expressed on dividing cells but absent from nondividing cells.The Journal of Experimental Medicine, 1980